Oral Formulation III

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oral Formulation III, covering 2025-07-17 to 2025-07-17. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation III [Phase 1]